Ellis Bio
Cambridge, US · 1 known investors
Ellis Bio develops epigenomics technologies, offering methylation conversion kits (SuperMethyl Max and SuperMethyl Fast) for DNA methylation analysis of low-input and cell-free DNA samples. Its products serve researchers and clinicians working on genomic and cancer methylation profiling workflows.
Investors · 1
In the news
Frequently asked questions
- What does Ellis Bio do?
- Ellis Bio develops epigenomics technologies, offering methylation conversion kits (SuperMethyl Max and SuperMethyl Fast) for DNA methylation analysis of low-input and cell-free DNA samples. Its products serve researchers and clinicians working on genomic and cancer methylation profiling workflows.
- Who are Ellis Bio's investors?
- Ellis Bio's investors include Undeterred Capital.
- Where is Ellis Bio headquartered?
- Ellis Bio is headquartered in Cambridge, US.